News
SHANGHAI, May 4, 2025 /PRNewswire/ -- On April 23, 2025, Nutshell Therapeutics ( Shanghai) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical trial in the United States ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback